Documents
Application Sponsors
Marketing Status
Application Products
001 | EMULSION; OPHTHALMIC | 0.1% | 2 | VERKAZIA | CYCLOSPORINE |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2021-06-23 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
SANTEN
cder:Array
(
[0] => Array
(
[ApplNo] => 214965
[companyName] => SANTEN
[docInserts] => ["",""]
[products] => [{"drugName":"VERKAZIA","activeIngredients":"CYCLOSPORINE","strength":"0.1%","dosageForm":"EMULSION; OPHTHALMIC","marketingStatus":"Prescription","te":"","rld":"TBD","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/23\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD; Orphan","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/214965Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-06-23
)
)